Skip to content

Study finds that 8% of newly diagnosed HIV patients in US have drug resistance

Tipranavir access expanded, but doctors warned on double boosted PI regimens

HAART is effective in prisoners, but benefit may be lost upon release

Early treatment with a four-drug combination a good option for HIV-infected infants

New report on palliative care and HIV: recommendations and resources

Prevention tactics need to change as treatment scales up, say experts

Dietary supplements can improve diarrhoea and increase antiretroviral drug levels in AIDS patients

French IV drug users who report HAART side-effects have more risky sex

HIV type 2 may not be well controlled by HAART regimens that work against HIV-1